Independence Blue CrossMedicare Advantage · Administrative · Medical Policy · Neurology, Pain Management, Family Medicine +1 moreLow impact
MA05.071, Remote Electrical Neuromodulation for Migraines
Effective date
Jan 1, 2026
Identified
Jun 19, 2026
Summary
Independence Blue Cross reissued MA05.071 with no substantive changes to remote electrical neuromodulation (REN/Nerivio) coverage for migraine prevention. The policy maintains existing coverage criteria for adults (18+) and pediatric patients (8-17) who meet specific headache frequency and medication response thresholds, and continues to exclude acute migraine treatment as experimental/investigational. This is an annual review reissuance effective 01/01/2026 with no billing workflow changes required.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
02This is a reissue with no changes to the existing policy.
03Billing team should verify that current authorization and billing procedures for Nerivio (HCPCS A4540) under MA05.071 remain unchanged and continue to require: (1) documentation of 6-24 headache days per 28-day period for 3 months prior to device use, (2) failure/contraindication/intolerance to two or more preventive medications (or pregnancy/breastfeeding/MOH risk/drug interactions), and (3) ongoing compliance and clinical benefit for continued coverage.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.